EVR

Evercore recently announced that John Pissanos has joined the firm as a senior managing director in its healthcare investment banking group, based in London and focusing on life science tools, diagnostics, and medtech. His move from J.P. Morgan, where he led EMEA life science tools and diagnostics, adds specialized sector expertise that could deepen Evercore’s healthcare advisory capabilities in E

How Evercore’s New Healthcare Hire Connects To The Stock Evercore (EVR) recently appointed John Pissanos as a senior managing director in its healthcare investment banking group, focusing on life science tools, diagnostics and medtech from a London base. Pissanos brings nearly 15 years of investment banking experience, most recently at J.P. Morgan as head of EMEA life science tools and diagnostics

The upgrade to Outperform comes after a 50% decline over the past year

LONDON, September 01, 2026--Evercore announced today that John Pissanos has joined the firm as a senior managing director in its healthcare investment banking group, focused on life science tools & diagnostics and medtech. He will be based in London.

Broadcom stock is in the spotlight as it prepares to publish its financial results. Here's what to expect when the numbers come out

SpaceX’s (NASDAQ:SPCX) ambitions to move computing infrastructure into orbit could become more attractive as political resistance to terrestrial data centers intensifies across the US, Evercore ISI said in a note to investors. Analyst Kutgun Mural pointed to an increasingly difficult political and regulatory environment for new data center developments.

Evercore (EVR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital. The select few that can do all three for many years are often the ones that make you life-changing money.